Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
I have appreciated the support from my manager, leadership and team. The environment at KPTI is fast paced with opportunity to innovate and try new things - with a priority and focus on people and patients first.
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
Teamwork and support from my KPTI colleagues
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
Being a resource and cross functional partner to my KPTI colleagues and leadership.
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
We are one team. Everyone supports each other regardless of their role or function. This allows us to achieve our goals and objectives.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×